A carregar...
Real world aspects of palliative trifluridine plus tiperacil (TAS-102) in refractory metastatic colorectal cancer
BACKGROUND: While recent randomised phase III trials show that trifluridine/tiperacil (TAS-102) may prolong life in patients with refractory metastatic colorectal cancer (rmCRC), palliative aspects on its efficacy and tolerability in real world patients need further elucidation. METHODS: A retrospec...
Na minha lista:
| Publicado no: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475330/ https://ncbi.nlm.nih.gov/pubmed/32953145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-43 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|